Pneumococcal conjugate vaccination in toddlers: Mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies

Pediatric Infectious Disease Journal

Volumn 18, Issue 9, 1999, Pages 764-772

  Nieminen, Tea ^a   Käyhty, Helen ^a   Leroy, Odle ^b   Eskola, Juhani ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Pasteur Mérieux Connaught ^*  (France)

Author keywords

Antibody secreting cells; Mucosal antibodies; Pneumococcal vaccination

Indexed keywords

DIPHTHERIA TOXOID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PNEUMOCOCCUS VACCINE; TETANUS TOXOID;

ANTIBODY PRODUCING CELL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DIPHTHERIA; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MUCOSAL IMMUNITY; PRIORITY JOURNAL; SALIVA ANALYSIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TETANUS; TREATMENT OUTCOME; VACCINATION;

ANTIBODIES, BACTERIAL; ANTIBODY-PRODUCING CELLS; BACTERIAL VACCINES; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; INFANT; POLYSACCHARIDES, BACTERIAL; SALIVA; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, CONJUGATE;

EID: 0344549183     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199909000-00005     Document Type: Article

References (39)

1. Mäkelä PH, Sibakov M, Herva E, Henrichsen J. Pneumococcal vaccine and otitis media. Lancet 1980;2:547-51.
2. Leinonen M, Säkkinen A, Kalliokoski R, Luotonen J, Timonen M, Mäkelä PH. Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Pediatr Infect Dis 1986;5:39-44.
3. Riley ID, Alpers M, Gratten H, Lehmann D, Marshall TFCD, Smith D. Pneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean children. Lancet 1986;2:877-81.
4. Braley-Mullen H. Antigen requirements for priming of IgG producing memory cells specific for type III pneumococcal polysaccharide. Immunology 1980;40:521-7.
5. Käyhty H, Åhman H, Rönnberg PR, Tillikainen R, Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis 1995;172:1273-8.
6. Andrson EL, Kennedy DJ, Geldmacher KM, Donnelly J, Mendelman PM. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr 1996;128:649-53.
7. Åhman H, Käyhty H, Tamminen P, Vuorela A, Malinoski F, Eskola J. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants. Pediatr Infect Dis J 1996;15: 134-9.
8. Dagan R, Melamed R, Zamir O, Leroy O. Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigen. Pediatric Infect Dis J 1997;16:1053-9.
9. Åhman H, Käyhty H, Lehtonen H, Leroy O, Froeschle J, Eskola J. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in infancy and able to induce immunologic memory. Pediatr Infect Dis J 1998;17:211-6.
10. Takala AK, Eskola J, Leinonen M, et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 1991;164:982-6.
11. Murphy TV, Pasor P, Medley F, Osterholm T, Granoff DM. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr 1993;122:517-23.
12. Mohle-Boetani J, Ajello G, Breneman E, et al. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae. Pediatr Infect Dis J 1993;12:589-93.
13. Takala AK, Santosham S, Almeido-Hill BS, et al. Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. Pediatr Infect Dis J 1993;12:593-9.
14. Dagan R, Muallem M, Melamed R, Leroy O, Yagupsky P. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphteria toxoid. Pediatric Infect Dis J 1996;16:1060-4.
15. Nieminen T, Käyhty H, Virolainen A, Eskola J. Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA response. Vaccine 1998;16:313-9.
16. Nieminen T, Eskola J, Käyhty H. Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum. Vaccine 1998;16:630-6.
17. Balows A, Hausler WJ Jr, Herrmann KL, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology. 5th ed. Washington, DC: American Society for Microbiology, 1991.
18. Quataert SA, Kirch CS, Laurie J, et al. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, Lot 89-S. Clin Diagn Lab Immunol 1995;2:590-7.
19. Virolainen A, Jero J, Käyhty H, Karma P, Leinonen M, Eskola J. Nasopharyngeal antibodies to pneumococcal capsular polysaccharides in children with acute otitis media. J Infect Dis 1995;172:1115-8.
20. Kauppi M, Eskola J, Käyhty H. Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines. Pediatr Infect Dis J 1995;14:286-94.
21. Tarkowski A, Lue C, Moldoveanu Z, Kiyono H, McGhee J, Mestecky J. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses. J Immunol 1990;144:3770-8.
22. Lue C, Tarkowski A, Mestecky J. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J Immunol 1988;140:3793-800.
23. Heilmann C, Henrichsen J, Pedersen FK. Vaccination-induced circulation of human B cells secreting type-specific antibodies against pneumococcal polysaccharides. Scand J Immunol 1987;25:61-7.
24. Heilmann C, Pedersen FK. Quantitation of blood lymphocytes secreting antibodies to pneumococcal polysaccharides after in vivo antigenic stimulation. Scand J Immunol 1986; 23:189-94.
25. Lue C, van den Wall Blake AW, Prince SJ, et al. Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response. Clin Exp Immunol 1994;96:356-63.
26. Brandzaeg P. Human secretory immunoglobulins: II. Salivary secretions in individuals with selectively excessive or defective synthesis of serum immunoglobulins. Clin Exp Immunol 1971;8:69-85.
27. Grönblad EA. Concentrations of immunoglobulins in human whole saliva: effect of physiological stimulation. Acta Odontol Scand 1981;40:87-95.
28. Korsud FR, Brandzaeg P. Quantitative immunohistochemistry of immunoglobulin-and J-chain-producing cells in human parotid and submandibular glands. Immunology 1980;39: 155-61.
29. Pichichero M, Hall C, Insel R. A mucosal response following systemic Haemophilus influenzae type b infection in children. J Clin Invest 1981;67:1482-9.
30. Pichichero M, Insel R. Mucosal antibody response to parenteral vaccination with Haemophilus influenzae type b capsule. J Allergy Clin Immunol 1983;72:481-6.
31. Åhman H, Käyhty H, Vuorela A, Leroy O, Eskola J. Dose-dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid. Vaccine 1999;17:2726-31.
32. Kauppi M, Saarinen L, Käyhty H. Anti-capsular antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rat. J Infect Dis 1993;167:365-71.
33. Malley R, Stack AM, Ferretti ML, Thompson CM, Saladino RA. Anticapsular polysaccharide antibodies and nasopharyngeal colonization with Streptococcus pneumoniae in infant rat. J Infect Dis 1998;178:878-82.
34. Schurin PA, Rehmus JM, Johnson CE, et al. Bacterial polysaccharide immunoglobulin for prophylaxis of acute otitis media in high risk children. J Pediatr 1993;123:801-10.
35. Sloyer JL Jr, Howie WM, Ploussard JH, Amman AJ, Austrian R, Jonston RB Jr. Immune response to acute otitis media in children. Infect Immun 1974;9:1028-132.
36. Sloyer JL Jr, Howie WM, Ploussard JH, Schiffman G, Jonston RB Jr. Immune response to acute otitis media: association between middle ear fluid antibody and the cleaning of clinical infection. J Clin Microbiol 1976;4:306-8.
37. Karjalainen H, Koskela M, Luotonen J, Herva E, Sipilä P. Antibodies against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis in middle ear effusion during early phase of acute otitis media. Acta Otolaryngol (Stockh) 1990;109:111-18.
38. Robbins JB, Schneerson R, Szu SC. Perspective:hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J Infect Dis 1995;171:1387-98.
39. Robbins JB, Schneerson R, Andersson P, Smith DH. The 1996 Albert Lasker Medical Research Awards: prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. JAMA 1996;276:1181-5.